FUJIFILM Medical Systems U S A , Inc Continues Support of Continuing Medical Education (CME) Programs for Medical Imaging Professionals fujifilm.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fujifilm.com Daily Mail and Mail on Sunday newspapers.
(1)
Brought to Australia and New Zealand in Partnership with AI Advance, Mia is the First and Only AI-Enabled Independent Reader for Breast Cancer Screening to Receive Clearance in Each Country
Marking a new milestone for artificial intelligence (AI) adoption in the Australian and New Zealand breast screening community, the Mia solution, created by United Kingdom-based Kheiron Medical Technologies, received Therapeutic Goods Administration (TGA) clearance from the Australian Government Department of Health and MedSafe WAND Notification from the New Zealand Ministry of Health as an AI-enabled independent reader for the early detection and diagnosis of breast cancer. Mia is being launched in partnership with AI Advance, an AI consulting services and software distribution company for the medical imaging industry based in Australia and New Zealand.
email article
Vinay Prasad, MD, MPH, breaks down a new study that examined differences in breast cancer screenings before and during the COVID-19 pandemic overall, and among sociodemographic population groups
.
Hey, welcome back. Vinay Prasad here for
MedPage Today, I m here with my segment, Articles You Will Definitely Read (Later). And I got a new article. It just came out in JAMA Network Open, and it s entitled Socioeconomic and Racial Inequities in Breast Cancer Screening During the COVID-19 Pandemic in Washington State.
So let s take a look into this study. This is a study that just appears in
JAMA Network Open, and the authors look at something very simple. Now we ve known all along that COVID-19 can disrupt healthcare systems in several ways.